AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 NOV 6 - (NewsRx.com & NewsRx.net) -- Luminescent imaging is a useful tool for evaluating anticancer drugs in vivo.
"Human DU-145 prostate and MCF-7 breast tumor cell lines were stably transfected with plasmid pcDNA3.1-Luc expressing firefly luciferase. Studies were performed with the transfected cell lines to evaluate luminescent imaging for measuring the efficacy of anticancer agents," scientists writing in the journal Anticancer Drugs report.
"In vitro experiments demonstrated a dose response of both cell lines to topotecan (Hycamtin) with an IC[subscript]50 of 0.013 microM for MCF-7 Luc cells and 0.002 microM for DU-145 Luc cells. In vivo imaging experiments were performed using athymic nude mice inoculated i.p. with 5 x 10[superscript]6 MCF-7 cells or s.c. with 5 x 10[superscript]6 DU-145 cells and then treated with topotecan at 2.5 mg/kg body weight," wrote G. Caceres and colleagues, Rumbaugh Goodwin Cancer Research Institute, Inc.
"Tumor progression and regression were monitored for 27 days. Animals inoculated s.c. with DU-145 Luc cells and then treated with topotecan demonstrated significant tumor growth and regression as measured with calipers and luminescent imaging," the researchers wrote.
"High correlation was observed between caliper and imaging results. The correlation coefficient was 0.75 for the control ...
Source: HighBeam Research, Luminescent imaging is a useful tool for evaluating anticancer drugs...